Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast
<p>Abstract</p> <p>Background</p> <p>Carcinoma-associated fibroblasts (CAFs) can promote carcinogenesis and tumor progression. Only limited data on the response of CAFs to chemotherapy and their potential impact on therapy outcome are available. This study was undertake...
Main Authors: | Simon Wolfgang, Friedel Godehard, Schroth Werner, Fritz Peter, Haubeiß Silke, van der Kuip Heiko, Sonnenberg Maike, Mürdter Thomas E, Aulitzky Walter E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-12-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/8/364 |
Similar Items
-
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
by: van der Kuip Heiko, et al.
Published: (2010-06-01) -
Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment
by: Simon Wolfgang, et al.
Published: (2006-04-01) -
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec&reg;, Gleevec&trade;)
by: Martin Henkes, et al.
Published: (2008-03-01) -
Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
by: Xinglong Geng, et al.
Published: (2021-07-01) -
Transcription factors in fibroblast plasticity and CAF heterogeneity
by: Roberta Melchionna, et al.
Published: (2023-12-01)